LABORATORIO FARMAC.ERFO (RK7) — Defensive Interval Ratio

Latest as of June 2024: 82 days

LABORATORIO FARMAC.ERFO (RK7) has a Defensive Interval Ratio of 82 days as of June 2024. Defensive assets of €553.63K (cash €-, short-term investments €-, receivables €553.63K) cover 82 days of daily cash needs of €6.78K/day. Check RK7 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

82 days
Days of operational coverage

Defensive Assets

€553.63K
Cash + ST Investments + Receivables

Daily Cash Need

€6.78K
Current Liabilities ÷ 365

Current Liabilities

€2.48 Million
EUR

LABORATORIO FARMAC.ERFO Defensive Interval Ratio (2021–2022)

This chart shows how LABORATORIO FARMAC.ERFO's Defensive Interval Ratio has evolved across 2 annual periods from 2021 to 2022. As of June 2024, the ratio stands at 82 days, meaning defensive assets of €553.63K can fund 82 days of operations without new revenue. Also explore RK7 year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for LABORATORIO FARMAC.ERFO (2021–2022)

The table below presents the year-by-year Defensive Interval Ratio for LABORATORIO FARMAC.ERFO from 2021 to 2022, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market value of LABORATORIO FARMAC.ERFO.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2022 72 days €404.51K €5.63K/day €- €- ▼ -29 days
2021 100 days €360.00K €3.59K/day €- €-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)